VIEWS: 1 PAGES: 8 CATEGORY: Healthcare Management POSTED ON: 6/26/2013
The U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market. U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market. Browse Report : http://www.transparencymarketresearch.com/us-vaccine-market.html
"U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research"